Publication: Demographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life study
dc.contributor.author | Suerdem, Mecit | |
dc.contributor.author | Günen, Hakan | |
dc.contributor.author | Akyıldız, Levent | |
dc.contributor.author | Çilli, Aykut | |
dc.contributor.author | Özlü, Tevfik | |
dc.contributor.author | Abadoğlu, Öznur | |
dc.contributor.author | Bayram, Hasan | |
dc.contributor.author | Cimrin, Arif Hikmet | |
dc.contributor.author | Gemicioğlu, Bilun | |
dc.contributor.author | Mısırlıgil, Zeynep | |
dc.contributor.buuauthor | Uzaslan, Esra | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Hastalıkları Bölümü | tr_TR |
dc.contributor.researcherid | AAI-1004-2021 | tr_TR |
dc.contributor.scopusid | 8761653500 | tr_TR |
dc.date.accessioned | 2024-01-29T12:38:26Z | |
dc.date.available | 2024-01-29T12:38:26Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Purpose: In order to determine the clinical and sociodemographic characteristics of newly diagnosed treatment-naïve asthma and COPD patients in Turkey, a multicenter study in 2012 was initiated . We aimed to investigate the characteristics and therapies of COPD patients in the original study in more detail. Patients and Methods: This nation-wide, multicentric, non-interventional, prospective, real-life observational cohort study was conducted in 122 centers. The newly diagnosed patients were not receiving any treatment before the recruitment. Their general characteristics, the combined GOLD 2011 COPD categories and exacerbation histories were noted. The patients were followed up with 3 voluntary visits for 1 year. Their adherence to the inhaled treatment according to GOLD 2011 was evaluated during follow-up visits. Results: The study included 776 COPD patients. Their mean age was 59.4±9.1 years, and 11.9% of the patients were female. 35.1% of the patients were in the GOLD 2011 C and D category. 12.6% are frequent exacerbators, and 52.8% had at least one comorbid condition. 71.8% overtreatment rate was detected. Their attendance rates for three follow-up visits became 55.9%, 32.9% and 18.7%, respectively. The adherence rate to the treatment was measured as 81.9%. Conclusion: Although these patients were diagnosed for the first time, the GOLD C and D categories and frequent exacerbator phenotype were found at a high rate. They were usually prescribed an overtreatment regimen. We think that newly diagnosed COPD patients should be evaluated carefully, and best effort should be made to treat these patients in accordance with the recommendations of the major COPD guidelines. | en_US |
dc.description.sponsorship | Abdi Ibrahim Ilac San. ve Tic. AS, Turkey | tr_TR |
dc.description.sponsorship | Abdi Ibrahim | tr_TR |
dc.description.sponsorship | Sanofi | tr_TR |
dc.description.sponsorship | AstraZeneca | tr_TR |
dc.description.sponsorship | Novartis | tr_TR |
dc.description.sponsorship | Deva | tr_TR |
dc.identifier.citation | Uzunaslan, E. vd. (2020). ''Demographic, Clinical and Management Characteristics of Newly Diagnosed COPD Patients in Turkey: A Real-Life Study''. International Journal of Chronic Obstuctive Pulmonary Disease, 15, 261-267. | en_US |
dc.identifier.doi | https://doi.org/10.2147/COPD.S211838 | |
dc.identifier.endpage | 267 | tr_TR |
dc.identifier.issn | 1178-2005 | |
dc.identifier.pubmed | 32103925 | tr_TR |
dc.identifier.scopus | 2-s2.0-85079468793 | tr_TR |
dc.identifier.startpage | 261 | tr_TR |
dc.identifier.uri | https://www.dovepress.com/demographic-clinical-and-management-characteristics-of-newly-diagnosed-peer-reviewed-fulltext-article-COPD | tr_TR |
dc.identifier.uri | https://hdl.handle.net/11452/39369 | |
dc.identifier.volume | 15 | tr_TR |
dc.identifier.wos | 000515242300001 | |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Dove Medical Press Ltd. | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.journal | International Journal of Chronic Obstuctive Pulmonary Disease | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | COPD | en_US |
dc.subject | Newly diagnosed | en_US |
dc.subject | Treatment naive | en_US |
dc.subject | Exacerbations | en_US |
dc.subject | Obstructive pulmonary-disease | en_US |
dc.subject | Healt-status | en_US |
dc.subject | Asthma | en_US |
dc.subject | Comorbidities | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Spirometry | en_US |
dc.subject | Countries | en_US |
dc.subject | Outcomes | en_US |
dc.subject.emtree | Beta adrenergic receptor stimulating agent | en_US |
dc.subject.emtree | Corticosteroid | en_US |
dc.subject.emtree | Long acting drug | en_US |
dc.subject.emtree | Muscarinic receptor blocking agent | en_US |
dc.subject.emtree | Respiratory tract agent | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Chronic obstructive lung disease | en_US |
dc.subject.emtree | Cohort analysis | en_US |
dc.subject.emtree | Comorbidity | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Disease exacerbation | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Medication compliance | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Observational study | en_US |
dc.subject.emtree | Patient attendance | en_US |
dc.subject.emtree | Patient compliance | en_US |
dc.subject.emtree | Prescription | en_US |
dc.subject.emtree | Prospective study | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Chronic obstructive lung disease | en_US |
dc.subject.emtree | Clinical practice | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Drug utilization | en_US |
dc.subject.emtree | Medication overuse | en_US |
dc.subject.emtree | Multicenter study | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Practice guideline | en_US |
dc.subject.emtree | Protocol compliance | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Turkey (bird) | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Comorbidity | en_US |
dc.subject.mesh | Disease progression | en_US |
dc.subject.mesh | Drug utilization | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Guideline adherence | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Medication adherence | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Practice guidelines as topic | en_US |
dc.subject.mesh | Practice patterns | en_US |
dc.subject.mesh | Physicians' | en_US |
dc.subject.mesh | Prescription drug overuse | en_US |
dc.subject.mesh | Prospective studies | en_US |
dc.subject.mesh | Pulmonary disease | en_US |
dc.subject.mesh | Chronic obstructive | en_US |
dc.subject.mesh | Respiratory system agents | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.mesh | Turkey | en_US |
dc.subject.scopus | Chronic Obstructive Lung Disease; Spirometry; Primary Care | en_US |
dc.subject.wos | Respiratory system | en_US |
dc.title | Demographic, clinical and management characteristics of newly diagnosed COPD patients in Turkey: A real-life study | en_US |
dc.type | Article | en_US |
dc.wos.quartile | Q2 | en_US |
dspace.entity.type | Publication |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: